New ASCERTAIN Video Series: How Are Medicines Priced and What Makes a Price Fair?

03. noviembre 2025

Share

In front of the camera are Professor Carin Uyl-de Groot, Project Coordinator of ASCERTAIN and Professor of Health Technology Assessment, and Professor Maureen Rutten-van Mölken, Professor of Economic Evaluation of Innovations for Health and Scientific Director of the Institute for Medical Technology Assessment (iMTA).

The videos provide clear, accessible explanations of key concepts behind the economics of medicine pricing and reimbursement — making complex ideas understandable for everyone.

What is Reference Pricing?

Maureen Rutten-van Mölken explains how countries determine medicine prices by comparing them with those of similar medicines or across other countries. She highlights the two main approaches — external and internal reference pricing — and the consequences these systems can have for access to medicines, especially in lower-income countries.

Watch now on YouTube.

What is a List Price for a Medicine?

Maureen Rutten-van Mölken discusses why there is no single price for a medicine and what the term list price really means. The video sheds light on how list prices serve as a basis for negotiations and why the debate about making actual (discounted) prices transparent remains controversial.

Watch now on YouTube.

What is a Fair Price?

Carin Uyl-de Groot explores what makes a medicine price fair. Fair pricing means finding a balance: ensuring affordability and access for patients and health systems, while still allowing companies to earn enough to fund innovation and future medical breakthroughs. Pricing policies and regulation are crucial in maintaining this equilibrium.

Watch now on YouTube.

How Do Patients Influence Decisions on Medicine Access?

Carin Uyl-de Groot explains how patient perspectives are increasingly shaping decision-making — from the development of a medicine to its approval and reimbursement. Patient experience provides valuable insights into quality of life, treatment priorities, and real-world outcomes that help guide fairer, more informed access decisions.

Watch now on YouTube.

Thanks to Myeloma Patients Europe (MPE), Maureen Rutten-van Mölken, and Carin Uyl-de Groot for bringing this video series to life.